QuantaMatrix

퀀타매트릭스 · 317690

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$44.9M (₩61.9B)

Overview

QuantaMatrix makes in-vitro diagnostic (IVD) devices, instruments that test blood, urine, and other bodily fluids outside the body to detect disease, guide treatment, and predict patient outcomes.

Its products are supplied to large hospitals and independent clinical-testing laboratories in Korea and internationally. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company focuses primarily on microbiology diagnostics, particularly devices that test for sepsis and bloodstream infections and determine which antibiotics will work against the bacteria found.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$2.7M
▲ +47.7% YoY
Operating profit · FY2025
−US$11.3M
Loss narrowed
Net income · FY2025
−US$14.1M
Loss narrowed

Revenue

  • FY2023US$2.3M
  • FY2024US$1.8M
  • FY2025US$2.7M

Operating profit

  • FY2023−US$16.3M
  • FY2024−US$11.7M
  • FY2025−US$11.3M

Net income

  • FY2023−US$15.6M
  • FY2024−US$14.6M
  • FY2025−US$14.1M

Key ratios (FY2025)

ROE
-48.6%
Debt/Eq
31.7%
Op. margin
-421.8%
Net margin
-527.6%
Rev. YoY
▲ +47.7%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.